13th Annual EDC & Beyond
April 28-30, 2009
Rosen Shingle Creek, Orlando, FL
www.iirusa.com/edc
Contact: Amy Xu at axu@iirusa.comRegister with Priority Code: XP1409ACT
IIR’s 13th annual EDC event puts the “Beyond” into your e-clinical systems, addressing the full e-clinical spectrum of technology and usage for optimal synergistic performance.
Join us as experts from sponsor companies, CROs, investigative sites and e-clinical service providers come together to share strategies that address the full spectrum of the most important EDC issues BEYOND just data capture, including:
Led by a notable speaking faculty, including Keynote Presenter NFL legend Terry Bradshaw, take part in comprehensive workshops, interactive sessions, and new case studies and panel discussions so you can bring back the latest ways of integrating e-technologies into coherent systems, using e-clinical beyond just data capture, implementing industry standardization initiatives, and engaging clinical site preferences. Visit our website at www.iirusa.com/edc for full agenda details.
Plus, take your networking beyond just EDC. This conference is co-located with the 18th annual Partnerships with CROs event! Maximize your conference experience by networking with over 600 companies and 1800 clinical professionals!
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.